Syncor signs Israeli radiopharmacy deal

Radiopharmacy firm Syncor International of Woodland Hills, CA, has agreed to license its technology to Israeli nuclear research agency Soreq and its subsidiary, Isorad, which plan to establish a radiopharmacy in Israel. In exchange for providing information and technical assistance to set up the radiopharmacy, Syncor will receive quarterly payments. Soreq is affiliated with the Israel Atomic Energy Commission and carries out advanced R&D projects, while Isorad sells and markets Soreq products to private businesses.